Tag Archives: Side Effects

CCHR Calls on FDA to Require Updated Antidepressant Warnings After Research Finds Withdrawal Symptoms Are Common

Withdrawal symptoms are experienced by nearly half of the people trying to quit antidepressants, even if tapered over several weeks, research finds. CCHR says prescribing information and medication guides do not adequately convey this widespread risk and calls on FDA to require updates. Continue reading

Posted in Big Muddy River Newsletter | Tagged , , , | Comments Off on CCHR Calls on FDA to Require Updated Antidepressant Warnings After Research Finds Withdrawal Symptoms Are Common

CCHR Calls on FDA to Update Antidepressant Information for Increased Risks of Stroke and Heart Disease

New research finds antidepressants increase the risk of stroke, atrial fibrillation, heart failure and other cardiovascular events. Continue reading

Posted in Big Muddy River Newsletter | Tagged , , , , , | Comments Off on CCHR Calls on FDA to Update Antidepressant Information for Increased Risks of Stroke and Heart Disease

Researchers Report Concern over Antidepressants Causing Long-Lasting Sexual Dysfunction; CCHR Calls on FDA to Act

Decades after sexual dysfunction caused by antidepressants was first reported to persist after patients stopped taking the drugs, how many people experience continuing sexual problems is still not known.  Citizens Commission on Human Rights calls on the FDA to address the issue without further delay.  Continue reading

Posted in Big Muddy River Newsletter | Tagged , , , , , | Comments Off on Researchers Report Concern over Antidepressants Causing Long-Lasting Sexual Dysfunction; CCHR Calls on FDA to Act

Clozapine (Really?) for Schizophrenia

Psychiatric drugs and psychiatric treatments are not workable. Continue reading

Posted in Big Muddy River Newsletter | Tagged , , , , , , , | Comments Off on Clozapine (Really?) for Schizophrenia

CCHR Calls on FDA to Release Results of Investigation into Alleged Sexual Assault, Research Misconduct in Psychedelic Clinical Trials

Evidence presented to the U.S. drug regulatory agency alleging sexual assault and suppression of adverse events in clinical trials of ecstasy raises urgent concerns about the safety of patients in psychedelic-assisted psychotherapy. Citizens Commission on Human Rights calls for public release of FDA investigation results. Continue reading

Posted in Big Muddy River Newsletter | Tagged , , , , , , , , | Comments Off on CCHR Calls on FDA to Release Results of Investigation into Alleged Sexual Assault, Research Misconduct in Psychedelic Clinical Trials

CCHR Commends FDA Decision: Psychedelic Drug Ecstasy Not Proven Safe or Effective Treatment for Traumatized Patients

The U.S. drug regulatory agency examined evidence presented by the company requesting approval for MDMA (ecstasy) and reports from experts examining that evidence before denying approval for the drug as mental health treatment. A medical journal has just retracted three MDMA therapy research papers for ethical violations. Continue reading

Posted in Big Muddy River Newsletter | Tagged , , , , | Comments Off on CCHR Commends FDA Decision: Psychedelic Drug Ecstasy Not Proven Safe or Effective Treatment for Traumatized Patients

Mothers’ Psychiatric Drug Use Increases Risk of Newborns Needing Urgent Medical Attention, New Research Finds

Expectant mothers considering psychiatric drugs should have the increased risks of premature birth and respiratory, circulatory, and feeding problems for their newborns fully disclosed to them by their prescribers. Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , | Comments Off on Mothers’ Psychiatric Drug Use Increases Risk of Newborns Needing Urgent Medical Attention, New Research Finds

CCHR Calls Attention to New Research Finding More Serious Risks to Elderly Dementia Patients from Antipsychotic Drugs

Citizens Commission on Human Rights calls for government action to make prescribers and caregivers of the elderly aware of the wider range of serious risks to dementia patients from antipsychotic drugs and to curtail the wrongful use of the drugs. Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , | Comments Off on CCHR Calls Attention to New Research Finding More Serious Risks to Elderly Dementia Patients from Antipsychotic Drugs

CCHR Applauds FDA Advisory Committee Rejection of Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress

Committee’s recommendation to reject as therapy the psychedelic drug MDMA, also known as the “date rape” drug Ecstasy, comes after evidence from clinical trials was deemed insufficient to establish safety or effectiveness. Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , | Comments Off on CCHR Applauds FDA Advisory Committee Rejection of Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress

Push for Use of Psychedelic Drugs as Mental Health Treatment Downplays Dangerous Risks, Citizens Commission on Human Rights Says in Protest

It is not known how psychedelic drugs are supposed to work as mental health treatment. Psychedelics carry the risks of devastating immediate and long-term harms, putting human lives and sanity at risk. Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , | Comments Off on Push for Use of Psychedelic Drugs as Mental Health Treatment Downplays Dangerous Risks, Citizens Commission on Human Rights Says in Protest